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Abstract  
The occurrence of renal and multiple organ Amyloïdosis is currently considered exceptional in the course of systemic lupus erythematosus. We 
report a case of a concomitant SLE and Amyloïdosis in a 57 year old female patient with hypothyroidism history, who presented with erythema 
nodosum, fever, arthralgia and sicca syndrome. Biological findings showed an inflammatory syndrome, renal failure, proteinuria (1g / 24h), positive 
auto antibodies and anti DNA. Lung radiology revealed medistinal lymphadenopathy, pleural nodules, ground glass infiltrates and pleuritis. 
Bronchial biopsy showed non specific inflammation. The salivary gland biopsy showed amyloïd deposits. This case report reminds us that lupus and 
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Systemic lupus erythematosus (SLE) is characterized by a large 
clinical polymorphism which explains the diagnostic difficulties 
encountered in some cases. Amyloidosis is histologically diagnosed 
by the presence of insoluble protein deposits in tissues. The AA 
amyloid form is secondary to a chronic inflammatory condition due 
to systemic diseases. The occurrence of renal and multiple organ 
amyloidosis is exceptional in the course of systemic lupus 




Patient and observation 
 
This is a 57 year old female with hypothyroidism history for 20 years 
who consulted for fever, arthralgia and erythema nodosum. She 
presented with a 10 day history of subcutaneous nodules in lower 
limbs, fever, and arthritis .On physical examination, there was 
hepatosplenomegaly, and no lymphadenopathy. On the skin 
examination there was hot nodules on the front and sides of the 
legs. On ophtalmological examination, there wa keratitis. Biological 
findings showed an elevated erythrocyte sedimentation rate (123 
mm during the first hour), a normocytic normochromic non-
regenerative anemia (9 g / dl), a positive polyclonal hyper gamma 
globulin rate (16 g / L), an elevated C-reactive protein rate (190 mg 
/ L), renal failure (creatinine 200 umol / l, Urea 16 mmol / l, Renal 
clearance: 28 ml / min), anti-nuclear and anti-native DNA antibodies 
were positive. There was also significant proteinuria (1g/day). 
Calcium and phosphate balance over a 3 day periods was normal. 
Chest X-ray showed Mediastinal enlargement suggestive of 
mediastinal adenomegaly with calcifications (Figure 1). On chest CT 
there was mediastinal lymph nodes in Barety space and bilateral 
hilar lymphadenopathy which were partially calcified. There were 
changes in the lung parenchyma described as ground glass 
infiltrates with pleural nodules, pleural and pericardial effusions 
(Figure 2). Tuberculin intradermal test was negative, 
mycobacteruim tuberculosis wasn't present in gastric fluid. On 
functional respiratory tests there was distal obstructive deficit with a 
normal DLCO. Bronchoscopy showed macroscopically normal 
bronchi. Bronchial biopsies suggested non specific inflammation 
lesions. Renal Ultrasound revealed poorly differentiated kidneys with 
a small left kidney, which didn't allow the renal biopsy. Skin biopsy 
was performed on healthy skin and showed no lupus band. Renal 
biopsy was contrindicated by the findings of the renal ultrasound. 
Biopsy of the salivary glands showed chronic sialadenitis the special 
Congo Redstain revealed amyloid deposits around the vessels and 
interlobular ducts (Figure 3) which are birefringent amyloid deposits 
under polarized light (Figure 4). Accordingly, the retained diagnosis 
was the association of SLE, sarcoidosis (Lofgren syndrome) and 
amyloidosis. Our patient has already been treated. There was a 
complete regression of the erythema nodosum lesions under 
analgesics and potassium iodide after 4 weeks. There were no 
indications for corticosteroid therapy because kidneys were already 
affected, CKD stage (Chronic kidney disease) with small 
dedifferentiated kidneys and there were no signs of activity of 
sarcoidosis. The patient was prescribed Colchicine® 1mg per day 
and Nivaquine® 200mg per day. The patient monitoring included a 
chest CT, a transthoracic echocardiography (which showed 
regression of the pericardial effusion), creatininemia and 






The association SLE and Sarcoidosis has been described in the 
literature as a non-fortuitous association [1]. The blocking of the 
reticuloendothelial purification system by immune complexes excess 
in SLE can enhance the formation sarcoid granulomas.Hepatitis C 
treatment with IFN-αcan induce sarcoidosis and SLE [2- 4]. There is 
common cytokininic channel stimulation between the two 
conditions. Amyloidosis is defined by the extracellular deposition of 
protein agglomerates all having common tinctorial affinity, a 
fibrillary appearance in electron microscopy, and a so-called spatial 
conformation β-pleated sheet [5, 6]. There are several types of 
amyloidosis according to the nature of the deposits of amyloid 
proteins [7]. AA amyloidosis is a complication of chronic 
inflammation (Rhumatoid arthritis, Ankylosing spondylitis, Crohn's 
disease, Juvenile idiopathic arthritis) or chronic infections such as 
tuberculosis. Amyloidosis almost never occurs as a complication of 
SLE [8,9]. There are a number of reasons which make LES and 
amyloidosis are mutually exclusive: there is low SAA protein levels 
during active lupus, whereas the developed amyloidosis secondary 
to SLE shows primarily elevated SAA protein levels (reactive 
amyloidosis) [10]. There have been nearly 30 reported cases that 
associate SLE and amyloidosis since 1956.It is most often an AA 
amyloidosis type. An AL amyloidosis has been described in some 
lupus with monoclonal gammopathy. The elapsed time from 
diagnosis of SLE and amyloidosis varies from 1year to 35 years. The 
diagnosis was concomitant in our patient.In half of the patients, 
amyloidosis appears in less than five years' time. The occurrence of 
amyloidosis mechanisms is not very much known.High levels of SAA 
proteins were found in cases where they were assayed, which 
showed strong correlation between elevated SAA and 
amyloïdogenesis. The diagnosis of amyloidosis was confirmed 
according to histopathological findings after pulmonary, renal, 
gastric, cardiac and cutaneous biopsies. The association Sarcoidosis 
and Amyloidosis has been described in the literature. Five cases 
where reported in the literature with renal amyloidosis. The 
diagnosis of sarcoidosis in our case is to be discussed. The clinical 
features are highly suggestive of Lofgren's Syndrome, staged II on 






Although concomitant SLE and amyloidosis is an exceptional 
combination it remains possible. Indeed amyloidosis can complicate 
any chronic inflammatory condition including SLE. It can be localized 
or generalized. Treatment is directly based on the management of 
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Figure 1: Chest X-ray showing Mediastinal enlargement  
Figure 2: Mediastinal lymph nodes in Barety space and bilateral 
hilar lymphadenopathy on chest CT  
Figure 3: Congo red stain: amyloid deposits around the vessels and 
interlobular ducts  
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Figure 2: Mediastinal lymph nodes in Barety space and 





Figure 3: Congo red stain: amyloid deposits around the 





Figure 4: Irefringent amyloid deposits under polarized light 
 
 
